Результаты поиска

Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.

Multiple myeloma (MM) is a common hematological malignancy resulting from clonal proliferation of plasma cells and is defined by criteria set forth by the international myeloma working group. Pulmonary hypertension (PH) is defined by an elevated mean pulmonary artery pressure >20 mmHg measured during right heart catheterization. Echocardiography-diagnosed PH is relatively common in patients with MM and has been associated with increased mortality, morbidity, and poor stem cell transplant outcomes. PH in patients with MM (PH-MM) is usually multifactorial in origin. MM disease-specific factors,

Citizen participation in patient prioritization policy decisions: an empirical and experimental study on patients' characteristics.

Health systems worldwide are grappling with the need to control costs to maintain system viability. With the combination of worsening economic conditions, an aging population and reductions in tax revenues, the pressures to make structural changes are expected to continue growing. Common cost control mechanisms, e.g. curtailment of patient access and treatment prioritization, are likely to be adversely viewed by citizens. It seems therefore wise to include them in the decision making processes that lead up to policy changes. In the context of a multilevel iterative mixed-method design a quanti

Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma

ObjectiveStudies have shown that serum circRNA can be used as a biomarker for many tumors. However, the role of exosomal circRNA in prognostic evaluation in patients with multiple myeloma (MM) remains unclear. In this study, we aimed to analyze the role of circulating exosomal circMYC in the relapse and prognosis of patients with MM.Materials and methodsCirculating exosomes from 122 patients with MM and 54 healthy people were isolated. Quantitative polymerase chain reaction was performed to measure circMYC exosomal expression. Kaplan-Meier survival curves with log-rank testing were used for es

Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma.

BackgroundDespite advances in the treatment of cancers over the last years, treatment options for patients with recurrent glioblastoma (rGBM) remain limited with poor outcomes. Many regimens have been investigated in clinical trials; however, there is a lack of knowledge on comparative effectiveness. The aim of this systematic review is to provide an overview of existing treatment strategies and to estimate the relative efficacy of these regimens in terms of progression-free survival (PFS) and overall survival (OS).MethodsWe conducted a systematic review to identify randomized controlled trial

Interaction among cells of bone, immune system, and solid tumors leads to bone metastases.

Bone metastases are a dismal consequence for different types of solid tumors, such as breast, prostate, lung, and kidney cancer. The mechanisms regulating the interactions among bone, immune system, and tumor cells have been deeply investigated, and many studies are ongoing to define the specific role of the different cells in the bone metastatic process. The affinity of some tumors to growth in bone results from the special microenvironment provided by bone. Moreover, immune system and bone have a bidirectional relationship: bone cells express surface molecules ruling the expansion of hemopoi

Многострановое исследование базы данных для оценки результатов беременности и младенчества после возможного воздействия кладрибинных таблеток на матерей или отцов при лечении множественного склероза: методы исследования КЛЕО и обновление статуса.

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Кладрибинные таблетки противопоставляются во время беременности; таким образом, данные о безопасности беременности, подверженной такому лечению, ограничены. СЛАР собирает и описывает результаты беременности в этой недостаточно изученной группе населения. ЦЕЛИ: Описание основных особенностей структуры исследования, проведенного в рамках программы < < ЯДЕР > > , включая источники данных и методологический подход, и представление обновленной информации о ходе работы. DESIGN: CLEAR представляет собой неинтервенционное, многобазовое, сравнительное когортное исслед

Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study.

BackgroundAlthough isolated distal deep vein thrombosis (IDDVT) is a clinical complication for acute ischemic stroke (AIS) patients, very few clinicians value it and few methods can predict early IDDVT. This study aimed to establish and validate an individualized predictive nomogram for the risk of early IDDVT in AIS patients.MethodsThis study enrolled 647 consecutive AIS patients who were randomly divided into a training cohort (n = 431) and a validation cohort (n = 216). Based on logistic analyses in training cohort, a nomogram was constructed to predict early IDDVT. The nomogram was then va

Совпадение в полном тексте источника
… Baseline laboratory parameters, including albumin (ALB) levels, fasting blood glucose levels, serum creatinine concentration (SCr), homocysteine (Hcy) levels, the international normalized ratio (INR), fibrinogen levels, D-Dimer levels, c-reactive protein (CRP) levels, and high-sensitivity C-reactive …

Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel.

Caveolin-1 overexpression has previously been reported as a marker of endothelial injury in kidney chronic antibody-mediated rejection (c-ABMR), but conclusive evidence supporting its use for daily diagnostic practice is missing. This study aims to evaluate if Caveolin-1 can be considered an immunohistochemical surrogate marker of c-ABMR. Caveolin-1 expression was analyzed in a selected series of 22 c-ABMR samples and 11 controls. Caveolin-1 immunohistochemistry proved positive in peritubular and glomerular capillaries of c-ABMR specimens, irrespective of C4d status whereas all controls were n

Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma.

OBJECTIVES: Osteolytic bone lesions are common complications in multiple myeloma (MM), and can have an impact on quality of life due to the risk of fractures. Trabecular bone score (TBS) is a novel texture index derived from dual energy x-ray absorptiometry (DXA) of lumbar spine (LS) images that provides information about bone microarchitecture. The aim of this study was to evaluate whether TBS is useful in predicting bone fractures in MM patients. METHODS: TBS was calculated retrospectively from existing DXA images of the LS, in 20 patients with newly diagnosed MM. We analyzed the developmen

Developments in nanotechnology approaches for the treatment of solid tumors.

Nanotechnology has revolutionized cancer therapy by introducing advanced drug delivery systems that enhance therapeutic efficacy while reducing adverse effects. By leveraging various nanoparticle platforms-including liposomes, polymeric nanoparticles, and inorganic nanoparticles-researchers have improved drug solubility, stability, and bioavailability. Additionally, new nanodevices are being engineered to respond to specific physiological conditions like temperature and pH variations, enabling controlled drug release and optimizing therapeutic outcomes. Beyond drug delivery, nanotechnology pla

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.

PURPOSE OF REVIEW: Aberrant activation of the RAS-RAF-MEK-ERK signaling pathway contributes to numerous malignancies, congenital syndromes, and cardiovascular disorders, establishing MEK inhibitors (MEKi) as crucial therapeutic agents. MEKi demonstrate substantial clinical benefit as monotherapy (e.g., NF1-associated tumors) or combination therapy (e.g., melanoma, glioma, congenital RASopathies). Cardiovascular adverse events, primarily asymptomatic reductions in left ventricular ejection fraction (LVEF), have prompted intensive echocardiographic monitoring. RECENT FINDINGS: Emerging evidence

Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis.

Systemic amyloidoses are characterized by the unrelenting deposition of autologous proteins as highly ordered fibrils in target organs. The ensuing, potentially fatal organ dysfunction is the result of the combined damage caused by the proteotoxic effect of prefibrillar species and by the cytotoxicity and the structural alterations produced by the amyloid fibrils. Current therapy is focused on eliminating the amyloid protein, thus extinguishing the amyloid cascade at its origin. While this approach may end the cell damage caused by prefibrillar aggregates and prevent further amyloid accumulati

Semen Quality in Patients with Hematological Malignancies: A Retrospective Monocentric Study in the Perspective of Personalized Oncofertility Medicine.

Background/Objectives: The hypothalamic-pituitary-testis axis is known to be dysregulated in patients with hematological malignancies. However, data on the association between the type of hematological malignancies and semen quality are discordant. In the era of personalized medicine, identifying disease-specific patterns of reproductive impairment is crucial to optimize fertility preservation strategies. While patients with leukemia often show a clear deterioration in semen quality, studies on Hodgkin and non-Hodgkin lymphomas have shown that spermatogenesis is not always compromised. Indeed,

Multiple Myeloma: A Review of the Literature and a Case Report Highlighting the Immunocompromised State of Myeloma Patients.

Multiple myeloma (MM), a malignancy involving plasma cells, disproportionately affects older adults with an average age of diagnosis of about 70 years. Oftentimes, the therapies used in the treatment of MM are associated with a risk for immunotoxicity, lowering the ability of the immune system to fight off opportunistic infections. This is an important relationship for clinicians to realize as the incidence of opportunistic infections in myeloma patients is increasing. As an example, we present a case of a patient with MM who subsequently developed a cryptococcal infection. Our paper will high

QoL во время вводного курса KTd или KRd, за которым следует обслуживание или наблюдение K при пересадке пациентов с недавно диагностированным множественным миелом: продольный и перекрестный анализ случайного AGMT 02 Учёба.

Понимание влияния вводного и алиментного лечения на качество жизни пациентов (QoL) имеет важное значение для выбора лечения. Цель этого исследования заключается в сопоставлении сообщаемого пациентами QoL между пациентами, лечащимися с помощью вводно-ознакомительной терапии KTd или KRd, и терапией или наблюдением по обслуживанию K. Оценка QoL проводилась с использованием EORTC QOL-C 30 и QOL-MY20 Вопросники в вопроснике AGMT-02 исследования, в которых 123 пациенты с недавно поставленным диагнозом пересадки, не имеющие права на получение нескольких миэломы, были случайны: nine циклы индукционной

Transient increase in skeletal-related events after discontinuation of high-dose denosumab in cancer patients.

BACKGROUND: Denosumab is widely used to prevent skeletal-related events (SREs) in patients with bone metastases. However, rebound bone resorption after discontinuation is recognized. In osteoporosis, discontinuation of low-dose denosumab increases multiple vertebral fractures, but data on high-dose discontinuation remain limited. METHODS: Among 493 patients treated with high-dose denosumab at our institution (2014-2023), 78 met eligibility criteria. SREs during and after treatment were compared using each patient as their own control. SREs were defined as pathological fracture, spinal cord co

Схематическая оценка недостаточности витамина D в связи с аутоиммунными расстройствами и их последствий для внутренней медицины.

Иммунная система в значительной степени зависит от витамина D в том, что касается ее функции, несмотря на тот факт, что дефицит этого питательных веществ в настоящее время широко признается в качестве фактора, способствующего развитию нескольких аутоиммунных расстройств. В ходе этого исследования было установлено наличие дефицита витамина D у пациентов, страдающих аутоиммунной болезнью, и были исследованы его последствия для внутренней медицины. Два медицинских следователя искали в нескольких электронных базах данных, таких, как PubMed, Scopus, Web of Science и Google Scientific, для проведени

Требования пользователей к количественным радиологическим отчётам при множественном склерозе.

ЦЕЛИ: Количественные радиологические отчеты (Q Reports) могут способствовать совершенствованию клинического управления множественным склерозом (MS) путем включения количественных данных, полученных в ходе сканирования МРТ. Однако отсутствие консенсуса в отношении конкретной информации для включения в нее данных о предпочтениях и предпочтениях врачей препятствует внедрению этих инструментов анализа изображений. Цель этого исследования состоит в том, чтобы облегчить клиническое внедрение QReports путем определения требований врачей в отношении их использования в управлении НР. МАТЕРИАЛЫ И МЕТОДЫ

Global variations in elderly cancer mortality pattern in 2020 & prediction to 2040: A population-based study.

Background & objectives Cancer contributes to decreasing life expectancy, especially in low- and middle- income countries (LMIC) and countries in transition where resources for diagnosis and care are limited. As the world population is ageing, and by 2050, two-thirds of the population in LMIC will be elderly, the greater impact of cancer on the expectation of life in years at a given age of an adult will be seen in these countries. Methods Estimated cancer mortality for older adults (60 yr or above) was estimated using statistics available on Globocan 2020 platform (gco.iarc.fr). This platform

Waldenström macroglobulinemia treatment algorithm 2018.

Waldenström macroglobulinemia is often an indolent disorder, and many patients are candidates for observation with careful monitoring. For symptomatic patients, one must distinguish between those patients whose symptoms are related to immunologic manifestations associated with the IgM monoclonal protein and those that have symptoms related to progressive marrow and nodal infiltration with lymphoplasmacytic lymphoma. In Waldenström macroglobulinemia, the driver for therapy in the majority of patients is progressive anemia, secondary to bone marrow replacement by lymphoplasmacytic lymphoma. Rece